Class of 2025
For revolutionizing non-invasive liquid biopsy techniques for early cancer detection in tobacco-associated tumors, as well as being the first to identify genetic alterations in body fluids, leading to significant advancements in diagnostic methods and therapeutic drug development.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]